Signalling a new era in cancer care, this week the US Food and Drug Administration approved the first treatment that genetically engineers patients’ own blood cells.
Transform your clinical trials with Archer’s unparalleled accuracy and efficiency
visit our website, request a demo, or contact us at sales@ignitedata.com to learn more.